JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McVey, D. C.
Right arrow Articles by Vigna, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McVey, D. C.
Right arrow Articles by Vigna, S. R.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Endocannabinoids Induce Ileitis in Rats via the Capsaicin Receptor (VR1)

Douglas C. Mcvey, Patricia C. Schmid, Harald H. O. Schmid, and Steven R. Vigna

Departments of Cell Biology and Medicine, Duke University Medical Center, Veterans Affairs Medical Center, Durham, North Carolina (D.C.M, S.R.V.); and the Hormel Institute, University of Minnesota, Austin, Minnesota (P.C.S, H.H.O.S.)

Intraluminal administration of the endocannabinoids N-arachidonoyl-ethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG) causes inflammation similar to that caused by Clostridium difficile toxin A in the rat ileum. The effects of anandamide and 2-AG were significantly inhibited by pretreatment with the specific capsaicin receptor (vanilloid receptor subtype 1; VR1) antagonist capsazepine. Pretreatment with the CB1 and CB2 cannabinoid receptor antagonists N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR141716) and N-[1S)-endo-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) did not affect the responses to anandamide. It has previously been shown that intraluminal toxin A stimulates substance P (SP) release from primary sensory neurons and that pretreatment with SP receptor [neurokinin (NK)-1 receptor] antagonists inhibits the inflammatory effects of toxin A. Anandamide stimulated SP release and this was blocked by capsazepine pretreatment. Also, pretreatment with the specific NK-1 receptor antagonist (2S,3S)-3-([3,5-bis[trifluoromethyl)phenyl]methoxy)-2-phenylpiperidine (L-733,060) significantly inhibited the inflammatory effects of both toxin A and anandamide. Toxin A increased tissue concentrations of anandamide and 2-AG in the ileum, and these effects were enhanced after pretreatment with inhibitors of fatty acid amide hydrolase, a major endocannabinoid-degrading enzyme. The toxin A-stimulated release of anandamide but not 2-AG was selective over their congeners. These results demonstrate that the endocannabinoids anandamide and 2-AG stimulate intestinal primary sensory neurons via the capsaicin VR1 receptor to release SP, resulting in enteritis, and that endocannabinoids may mediate the inflammatory effects of toxin A.


Received August 4, 2002; accepted October 3, 2002.

Address correspondence to: Steven R. Vigna, Department of Cell Biology, Box 3709, Duke University Medical Center, Durham, NC 27710. E-mail: srv{at}duke.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Cheng, S. de la Monte, J. Ma, J. Hong, M. Tong, W. Cao, J. Behar, P. Biancani, and K. M. Harnett
HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G135 - G143.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. S. Lin, R.-L. Lin, M.-Y. Bien, C.-Y. Ho, and Y. R. Kou
Sensitization of capsaicin-sensitive lung vagal afferents by anandamide in rats: role of transient receptor potential vanilloid 1 receptors
J Appl Physiol, April 1, 2009; 106(4): 1142 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wang, H. Wang, W. Ning, M. G. Backlund, S. K. Dey, and R. N. DuBois
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Cancer Res., August 1, 2008; 68(15): 6468 - 6476.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A A Izzo and M Camilleri
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Gut, August 1, 2008; 57(8): 1140 - 1155.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
V Di Marzo and A A Izzo
Endocannabinoid overactivity and intestinal inflammation.
Gut, October 1, 2006; 55(10): 1373 - 1376.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F Guagnini, M Valenti, S Mukenge, I Matias, A Bianchetti, S Di Palo, G Ferla, V Di Marzo, and T Croci
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P
Gut, July 1, 2006; 55(7): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Fujino, S G de la Fuente, Y Takami, T Takahashi, and C R Mantyh
Attenuation of acid induced oesophagitis in VR-1 deficient mice
Gut, January 1, 2006; 55(1): 34 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Dinis, A. Charrua, A. Avelino, M. Yaqoob, S. Bevan, I. Nagy, and F. Cruz
Anandamide-Evoked Activation of Vanilloid Receptor 1 Contributes to the Development of Bladder Hyperreflexia and Nociceptive Transmission to Spinal Dorsal Horn Neurons in Cystitis
J. Neurosci., December 15, 2004; 24(50): 11253 - 11263.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.